Study Summary
This study aims to evaluate whether an innovative combination therapy (CLL1 CAR-T sequential allogeneic hematopoietic stem cell transplantation) is safe, feasible and effective for the treatment of relapsed/refractory acute myeloid leukemia (R/R AML).
Want to learn more about this trial?
Request More InfoInterventions
CLL1 CAR-T Cell Sequential Allogeneic Hematopoietic Stem Cell TransplantationDRUG
CLL1 CAR-T Cell Sequential Allogeneic Hematopoietic Stem Cell Transplantation
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology | Wuhan | Hubei | China |